Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

16
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

14
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Early timepoint <sup>99m</sup>Tc-DPD whole body scintigraphy and quantitative SPECT/CT imaging for diagnosis of cardiac ATTR amyloidosis.

EJNMMI research·2026
Same author

[Position paper of the German Society of Cardiology-quality criteria for performing catheter ablation of atrial fibrillation: executive summary].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same author

Impact of Inflow Gradients on Mortality and Heart Failure Hospitalizations Following Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights from the PASTE Registry.

JACC. Cardiovascular imaging·2026
Same author

Prognostic parameters and detection of cardiac amyloidosis with hybrid <sup>18</sup>F-Florbetaben-PET/MRI: an exploratory observational study.

European journal of nuclear medicine and molecular imaging·2026
Same author

Current treatment decisions in cardiac transthyretin amyloidosis: a multicentre analysis.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Nuclear cardiology - Current status of the clinical application.

Nuklearmedizin. Nuclear medicine·2026

相关实验视频

Updated: Jul 25, 2025

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

17.4K

在超性阻塞性心肌病症中 Septal 微球栓塞.

Emyal Alyaydin1, Rolf Alexander Jánosi1, Peter Luedike1

  • 1Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany.

The American journal of cardiology
|June 25, 2023
PubMed
概括

隔膜微球栓塞 (SME) 有效地减少左心室外流通道阻塞在心肌缩症患者. 这项研究表明,SME是酒精隔膜切除的安全有效替代方案.

科学领域:

  • 心脏病学 心脏病学
  • 干预心脏病学 干预心脏病学
  • 医疗器械 医疗器械

背景情况:

  • 患有左心室外流通道 (LVOT) 阻塞的高性心肌病 (HCM) 通常通过酒精隔膜切除来治疗.
  • 隔膜微球栓塞 (SME) 对LVOT阻塞的安全性和有效性以前没有得到评估.

研究的目的:

  • 为了评估隔膜微球栓塞 (SME) 的安全性和有效性,在患有LVOT阻塞的患者中使用75μm微球.
  • 为了比较中小企业的结果与已建立的治疗方法,如酒精隔膜切除.

主要方法:

  • 在2006年至2021年间接受SME治疗的76名患者的回顾性分析.
  • 主要终点:LVOT梯度的减少. 二级终点:周围手术死亡率,导电障碍,接入部位并发症和住院时间.

主要成果:

  • 中小企业显著减少了休息 (平均 Δ PG = -71%) 并引起 (平均 Δ PG = -75%) LVOT梯度.
  • 术周死亡率为1%,其中7%经历了完整的心房阻塞和5%的入口部位并发症.
  • 平均住院时间为13天.

结论:

  • 隔膜微球栓塞 (SME) 是一种安全有效的替代治疗方法,用于HCM中LVOT阻塞.

更多相关视频

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

784
Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
09:22

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

Published on: November 4, 2015

12.3K

相关实验视频

Last Updated: Jul 25, 2025

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

17.4K
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

784
Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
09:22

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

Published on: November 4, 2015

12.3K
  • 需要进一步的前性研究来充分阐明微球使用的优势.